Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.
第一作者:
Wen-Xue,Sun
第一单位:
State Key Laboratory of Pharmaceutical Biotechnology, Institute of Plant Molecular Biology, School of Life Sciences, Nanjing University, Nanjing 210023, PR China; Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing 210037, PR China.
作者:
关键词
Afatinib (PubChem CID: 10184653)AnticancerBenzene (PubChem CID: 241)BenzoylacrylicBromobenzene (PubChem CID: 7961)Chlorobenzene (PubChem CID: 7964)Colchicine (PubChem CID: 6167)Epidermal growth factor receptorFluorobenzene (PubChem CID: 10008)Maleic anhydride (PubChem CID: 7923)Methylbenzene (PubChem CID: 1140)Paclitaxel (PubChem CID: 36314)ShikoninShikonin (PubChem CID: 479503)Tubulin
主题词
丙烯酸盐类(Acrylates);动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);苯甲酸盐类(Benzoates);药物设计(Drug Design);人类(Humans);小鼠, 裸(Mice, Nude);萘醌类(Naphthoquinones);肿瘤(Neoplasms);微管蛋白(Tubulin);微管蛋白调节因子(Tubulin Modulators)
DOI
10.1016/j.bmc.2019.115153
PMID
31648877
发布时间
2020-09-24
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文